These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6891235)

  • 41. [Therapy of cerebral vascular insufficiency].
    Hirsch W; Woschée G
    Ther Ggw; 1967 Sep; 106(9):1186-7 passim. PubMed ID: 5623071
    [No Abstract]   [Full Text] [Related]  

  • 42. [Determination of the anti-anoxia capacity of drugs].
    Truchaud M
    Sem Hop Ther; 1977 Nov; 53(9):425-9. PubMed ID: 341317
    [No Abstract]   [Full Text] [Related]  

  • 43. [New aspects in the therapy of cerebrovascular diseases. Hemodynamic studies with a combination of coumarin-rutin-theophylline].
    Klein K
    Arzneimittelforschung; 1974 Jul; 24(7):1066-9. PubMed ID: 4408076
    [No Abstract]   [Full Text] [Related]  

  • 44. [Use of pikamilon in the combined treatment of patients with cerebral circulatory disorders].
    Zinchenko VA; Popov EA; Kalinichev SN; Lobzhanidze PV
    Vrach Delo; 1988 Dec; (12):18-9. PubMed ID: 3245153
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of acute cerebrovascular insufficiency using Instenon].
    Eichhorn O
    Wien Klin Wochenschr; 1969 Oct; 81(40):697-700. PubMed ID: 5344304
    [No Abstract]   [Full Text] [Related]  

  • 46. [Ambulatory treatment of cerebrovascular disorders including encephalographic and ophthalmologic studies].
    Leube H; Schwaeppe C
    Med Monatsschr; 1970 Aug; 24(8):366-9. PubMed ID: 5515138
    [No Abstract]   [Full Text] [Related]  

  • 47. Calcium modulation and clinical effect. Profile of cyclandelate.
    Timmerman H
    Drugs; 1987; 33 Suppl 2():1-4. PubMed ID: 3622303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclandelate: calcium modulation and clinical effects. Proceedings of a symposium. Helsinki, 14-15 November, 1986.
    Drugs; 1987; 33 Suppl 2():1-141. PubMed ID: 3622302
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of cardiac and cerebrovascular insufficiency with Card-Cosaldon. Result of a field study].
    Koeppen G; Schmidt-Modrow G
    Ther Ggw; 1979 Nov; 118(11):1704-13. PubMed ID: 538738
    [No Abstract]   [Full Text] [Related]  

  • 50. A pilot study to evaluate the effect of acute and long-term administration of cyclandelate on the vigilance of subjects submitted to hypoxic conditions. Preliminary report.
    Schaffler K; Hörmann E; Arnold H
    Arzneimittelforschung; 1981; 31(6):1032-5. PubMed ID: 7196236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclandelate in the management of tinnitus: a randomized, placebo-controlled study.
    Hester TO; Theilman G; Green W; Jones RO
    Otolaryngol Head Neck Surg; 1998 Mar; 118(3 Pt 1):329-32. PubMed ID: 9527112
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Therapy of cerebral insufficiency in the practice].
    Göhring H
    Med Welt; 1968 Aug; 32():1737-40. PubMed ID: 4388458
    [No Abstract]   [Full Text] [Related]  

  • 53. The use of cyclandelate in chronic brain syndrome with arteriosclerosis.
    Fine EW
    Curr Ther Res Clin Exp; 1971 Sep; 13(9):568-74. PubMed ID: 5000458
    [No Abstract]   [Full Text] [Related]  

  • 54. Cydandelate for cerebrovascular disease.
    Drug Ther Bull; 1968 Nov; 6(23):92. PubMed ID: 5697287
    [No Abstract]   [Full Text] [Related]  

  • 55. Modes and mechanisms of action of vasoactive drugs and especially of cyclandelate.
    Timmerman H
    Br J Clin Pract Suppl; 1984; 34():10-9. PubMed ID: 6430317
    [No Abstract]   [Full Text] [Related]  

  • 56. Benefits of cyclandelate in the treatment of disorders of ageing.
    Le Poncin-Lafitte M
    Br J Clin Pract Suppl; 1984; 34():58-61. PubMed ID: 6430325
    [No Abstract]   [Full Text] [Related]  

  • 57. [A new product acting on cerebral circulation: results of the use in neurosurgery of 7-(2 hydroxy-3-N-2-hydroxy-ethyl-N-methylamino propyl) 1-3 dimethylaxanthine pyridine-3-carboxyl or complamin].
    Pouyanne H; Guérin J; Maurin P
    J Med Bord; 1967 Nov; 114(11):1693-702. PubMed ID: 5602594
    [No Abstract]   [Full Text] [Related]  

  • 58. [Study of cyclandelate vaso-active properties by the measure of the ear-retina time in the rabbit (author's transl)].
    Andermann C; Andermann G; Ehinger C
    Ann Pharm Fr; 1980; 38(3):253-60. PubMed ID: 7425477
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacokinetics of etofylline after intravenous and oral administration to humans.
    Zuidema J; Verhoeven J; Merkus FW
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):310-3. PubMed ID: 7263108
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Possibilities of inspecting the action of drugs on the circulatory system].
    Gros C; Weill J; Vrousos C; Turpel A
    J Radiol Electrol Med Nucl; 1967; 48(1):97-8. PubMed ID: 6030146
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.